Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

41.81
BATS BZX Real-Time Price
As of 12:05pm ET
 -0.48 / -1.14%
Today’s Change
36.00
Today|||52-Week Range
46.38
-6.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line6.0B2.6B2.3B4.4B
 
 
 
 
 
Depreciation2.8B1.7B1.5B1.5B
 
 
 
 
 
Total Other Cash Flow2.4B266.0M333.0M-2.8B
 
 
 
 
 
Funds From Operations11.2B4.6B4.2B3.1B
 
 
 
 
 
Funds From/For Other Operating Expenses1.9B1.2B490.0M156.0M
 
 
 
 
 
Net Cash Flow - Operating Activities9.3B3.3B3.7B3.0B
 
 
 
 
 
 
InvestingIncrease In Investments-12.0B-10.1B-1.5B-4.9B
 
 
 
 
 
Decrease In Investments8.9B7.8B5.6B6.4B
 
 
 
 
 
Capital Expenditures-1.8B-1.1B-1.1B-1.1B
 
 
 
 
 
Fixed Asset Disposal------230.0M
 
 
Net Assets From Acquisitions -1.2B-580.0M-3.3B-235.0M
 
 
 
 
 
Other Investing - Sources2.7M21.0M75.0M52.0M
 
 
 
 
 
Net Cash Flow Investing-6.1B-3.9B-202.0M406.0M
 
 
 
 
 
 
FinancingShort Term Borrowings783.9M2.1B1.3B-1.3B
 
 
 
 
 
Long Term Borrowings14.7B9.0M0.002.5B
 
 
 
 
Long Term Debt Reduction-11.1B-303.0M-577.0M-57.0M
 
 
 
 
 
Net Proceeds Stock Sale1.9B395.0M429.0M314.0M
 
 
 
 
 
Common Preferred Redeemed-2.4B-1.6B-2.2B-2.2B
 
 
 
 
 
Common Dividends-3.2B-882.0M-1.3B-1.4B
 
 
 
 
 
Cash Dividends Paid - Total-3.2B-882.0M-1.3B-1.4B
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.006.4B400.0M17.0M
 
 
 
 
Net Cash Flow - Financing716.1M-6.7B-2.7B-2.2B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash40.1M-26.0M-143.0M-198.0M
 
 
 
 
 
 
Net Change In Cash3.9B-7.3B731.0M1.1B